Online citations, reference lists, and bibliographies.
← Back to Search

Folate Targeted PEGylated Liposomes For The Oral Delivery Of Insulin: In Vitro And In Vivo Studies.

Jafar Rahnama Yazdi, M. Tafaghodi, K. Sadri, Mohammad Mashreghi, A. R. Nikpoor, S. Nikoofal-Sahlabadi, J. Chamani, R. Vakili, Seyedeh Alia Moosavian, M. R. Jaafari
Published 2020 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In this study using phospholipids with high transition temperature and taking advantage of PEGylation, we designed liposomal formulation targeted with folic acid (FA) to improve the stability of liposomes with high penetration efficiency at the same time. The results of characterization demonstrated that liposomal formulations are in range of 150-210 nm size with negative surface charge. The results of cell uptake indicated that FA conjugation resulted in the more uptake of insulin. However, the results of transepithelial electrical resistance (TEER) showed no statistical differences among the formulations. The results of biodistribution also demonstrated that PEGylated liposome targeted with FA had more residence time in stomach and intestine along with higher amounts in blood and liver. The anti-diabetic effects of formulation in vivo indicated the efficacy of PEGylated liposome targeted with FA had promising results in decreasing blood glucose and increasing insulin levels. The results of this study indicated that using phospholipids with high Tm along with PEGylation and using targeting ligand could improve efficiency of oral delivery of liposomes which merit further investigation.
This paper references
10.1002/JPS.2600831020
Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs.
J. C. Scott-Moncrieff (1994)
10.1016/J.EJPB.2004.10.006
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.
U. Bilati (2005)
10.1002/JPS.2600840604
Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.
H. Asada (1995)
10.1016/j.addr.2012.09.041
Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.
S. Xu (2013)
10.1016/S0378-5173(01)00579-8
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat.
M. Kisel (2001)
10.1093/JN/131.11.2819
Folate receptor function is regulated in response to different cellular growth rates in cultured mammalian cells.
M. M. Doucette (2001)
10.4137/DTI.S0
Targeting Receptors, Transporters and Site of Absorption to Improve Oral Drug Delivery
J.H. Hamman (2007)
10.1016/S0378-5173(98)00102-1
W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: biological activity after oral administration to normal and diabetic rats
A. Silva-Cunha (1998)
10.1016/j.addr.2013.01.002
Targeted nanoparticles with novel non-peptidic ligands for oral delivery.
A. des Rieux (2013)
10.1016/J.JCONREL.2004.10.032
Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
Byoung-Yun Kim (2005)
10.1186/s40824-016-0083-1
Liposomal delivery systems for intestinal lymphatic drug transport
Hyeji Ahn (2016)
10.4239/wjd.v4.i1.1
Insulin therapies: Current and future trends at dawn.
S. Yaturu (2013)
10.1002/anie.200800865
Traveling the vitamin B12 pathway: oral delivery of protein and peptide drugs.
Amanda K. Petrus (2009)
10.1016/J.AB.2004.05.034
Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
Y. Zhang (2004)
Novel Approaches for Oral Delivery of Insulin and Current Status of Oral Insulin Products
P KineshV. (2010)
10.1016/B978-0-323-47720-8.00008-0
Challenges in oral drug delivery: a nano-based strategy to overcome
Pragasam Viswanathan (2017)
10.1016/j.apsb.2018.06.005
Adapting liposomes for oral drug delivery
Haisheng He (2019)
10.1016/j.nano.2013.07.011
Biotinylated liposomes as potential carriers for the oral delivery of insulin.
X. Zhang (2014)
10.1208/s12249-014-0282-9
Development of Acid-Resistant Alginate/Trimethyl Chitosan Nanoparticles Containing Cationic β-Cyclodextrin Polymers for Insulin Oral Delivery
Maryam Mansourpour (2014)
10.1016/j.nano.2017.08.010
Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies.
A. R. Nikpoor (2017)
10.1021/BM0503165
Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles.
M. Francis (2005)
10.3109/10611861003733953
Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration
K. Riviere (2011)
10.1177/193229681300700228
Oral Insulin Delivery: How Far are We?
P. Fonte (2013)
10.1016/j.apsb.2017.11.007
Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin
Haisheng He (2018)
10.1517/17425247.2010.501792
Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting
N. M. Zaki (2010)
10.22038/ijbms.2019.32873.7852
Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids
M. Hatamipour (2019)
10.7326/0003-4819-144-7-200604040-00005
Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 19882002
J. Saaddine (2006)
10.1016/J.COCIS.2010.12.005
Fate of polymeric nanocarriers for oral drug delivery
L. Plapied (2011)
10.1021/acs.molpharmaceut.5b00663
Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Shravan Kumar Sriraman (2016)
10.1016/j.ijpharm.2018.07.041
Recent advancements in oral administration of insulin‐loaded liposomal drug delivery systems for diabetes mellitus
Chun Y Wong (2018)
Preparation of iodine-125-labeled insulin for radioimmunoassay: comparison of lactoperoxidase and chloramine-T iodination.
B. Wajchenberg (1978)
10.4172/2157-7439.S4-007
Oral nano-insulin therapy: current progress on nanoparticle-based devices for intestinal epithelium-targeted insulin delivery
A. Ahmad (2011)
10.1016/j.jconrel.2017.09.003
Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment
Chun Y Wong (2017)
10.1186/1556-276X-9-185
Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity
X. Zhang (2014)
10.2147/IJN.S19917
Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation
M. Niu (2011)
10.1016/j.ijpharm.2015.08.048
Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model.
Amin Reza Nikpoor (2015)
10.1007/s00018-009-0053-z
Nanocarriers’ entry into the cell: relevance to drug delivery
H. Hillaireau (2009)
10.1089/1520915041705929
The physiological rationale for oral insulin administration.
E. Arbit (2004)
10.1016/S2222-1808(14)60672-1
Molecular identification of Leishmania species in Taybad district, Iran
Salehi Sangani Ghodratollah (2014)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1016/j.ejpb.2012.04.001
Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
V. Zabaleta (2012)
10.5772/52265
Oral Delivery of Insulin: Novel Approaches
Amani M. Elsayed (2012)
10.1016/0006-2952(87)90411-4
Absorption of protein via the intestinal wall. A quantitative model.
E. Ziv (1987)
10.1007/s10989-005-9010-3
Development and Comparison of Different Nanoparticulate Polyelectrolyte Complexes as Insulin Carriers
B. Sarmento (2005)
10.1615/critrevtherdrugcarriersyst.v14.i4.10
Drug delivery to the lymphatic system.
C. J. Porter (1997)
10.1021/bm401580k
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
10.1021/mp2005388
Folic acid functionalized nanoparticles for enhanced oral drug delivery.
Emilie Roger (2012)
10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
10.2147/IJN.S73340
Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation
X. Zhang (2014)
10.1186/1556-276X-7-299
Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery
Z. M. Wu (2012)
10.1016/S0378-5173(97)00237-8
Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract
K. Iwanaga (1997)
10.1016/j.addr.2015.09.012
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.
J. Suk (2016)
10.1021/jp4105745
Effect of PEGylation on drug entry into lipid bilayer.
Sami Rissanen (2014)



Semantic Scholar Logo Some data provided by SemanticScholar